NAFLD markers
Showing 1 - 25 of 9,626
Subclinical Cardiac Dysfunction in Non-Alcoholic Fatty Liver
Not yet recruiting
- NAFLD
- Echocardiographic findings
- (no location specified)
Nov 11, 2023
Permeability; Increased, NAFLD, Obesity Trial in Castellana Grotte (Ketogenic Diet)
Recruiting
- Permeability; Increased
- +2 more
- Ketogenic Diet
-
Castellana Grotte, Bari, ItalyIrccs Saverio de Bellis
Jul 25, 2022
HIV, Non-Alcoholic Fatty Liver Disease, Metabolic-Associated Steatotic Liver Disease Trial in Nashville (Prebiotic, Probiotic)
Not yet recruiting
- HIV
- +2 more
- Prebiotic
- Probiotic
-
Nashville, TennesseeVanderbilt University Medical Center
Oct 30, 2023
Fatty Liver, Diabetes, Type 2 Trial in Shiraz (Ginger, Placebo)
Completed
- Fatty Liver
- Diabetes Mellitus, Type 2
- Ginger
- Placebo
-
Shiraz, Fars, Iran, Islamic Republic ofShahid Motahhari Clinic, Shiraz University of Medical Sciences
Oct 17, 2020
Relation Between NAFLD and BM DENSITY
Not yet recruiting
- NAFLD
- Osteoporosis
- Fibroscan
- (no location specified)
Sep 14, 2023
Dynamic Post-Prandial Metabolism in Non-Alcoholic Fatty Liver
Completed
- Liver Disease
- Fatty Liver
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Non-Alcoholic Fatty Liver Disease Trial in Paris (Hepatic evaluation)
Recruiting
- Non-Alcoholic Fatty Liver Disease
- Hepatic evaluation
-
Paris, FrancePitié Salpêtrière Hospital
Sep 5, 2022
Biomarkers in the Diagnosis and Prognosis of NAFLD
Recruiting
- NAFLD
- +3 more
- Plasma Test
- +5 more
-
Trieste, ItalySilvia Palmisano
Oct 18, 2023
Non-alcoholic Fatty Liver Disease in Low Birth Weight
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- Low Birth Weight
- (no location specified)
Jun 6, 2023
Non-Alcoholic Fatty Liver Disease, Non Alcoholic Fatty Liver, Hepatic Steatosis Trial in Kyiv, Lviv (Probiotic lysate
Recruiting
- Non-Alcoholic Fatty Liver Disease
- +3 more
- Probiotic lysate (postbiotic and metabiotc)
- Placebo
-
Kyiv, Ukraine
- +3 more
Mar 27, 2023
Hepatocellular Carcinoma, Nonalcoholic Steatohepatitis Trial in Tarzana, New York, Durham (Lisinopril, Questionnaire
Recruiting
- Hepatocellular Carcinoma
- Nonalcoholic Steatohepatitis
- Biospecimen Collection
- +6 more
-
Los Angeles, California
- +3 more
Dec 8, 2022
Non-alcoholic Steatohepatitis Trial (Dapagliflozin 10Mg Tab, Pioglitazone 30 mg)
Not yet recruiting
- Non-alcoholic Steatohepatitis
- Dapagliflozin 10Mg Tab
- Pioglitazone 30 mg
- (no location specified)
Apr 23, 2022
Liver Diseases, Blood Disorder, Digestive System Disease Trial in Hershey (Aerobic Exercise)
Completed
- Liver Diseases
- +2 more
- Aerobic Exercise
-
Hershey, PennsylvaniaPenn State Hershey Medical Center
Jan 31, 2023
Non Alcoholic Fatty Liver Disease Trial in Athens (Mastiha, Placebo)
Completed
- Non Alcoholic Fatty Liver Disease
- Mastiha
- Placebo
-
Athens, Attica, GreeceHarokopio University
Apr 6, 2022
Non-Alcoholic Fatty Liver Disease Trial in Leiden (Exercise training)
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- Exercise training
-
Leiden, South Holland, NetherlandsLeiden University Medical Center
Aug 4, 2023
Non-Alcoholic Fatty Liver Disease, Gallstone Disease Trial in Molina (Physical exercise and dietary intervention for NAFLD)
Recruiting
- Non-Alcoholic Fatty Liver Disease
- Gallstone Disease
- Physical exercise and dietary intervention for NAFLD
-
Molina, Region Del Maule, ChileCentro MAUCO+
Jan 20, 2023
Non-Alcoholic Fatty Liver Disease Trial in United States (ALT-801, Placebo)
Active, not recruiting
- Non-Alcoholic Fatty Liver Disease
- ALT-801
- Placebo
-
Montclair, California
- +12 more
Oct 11, 2022
Non-Alcoholic Fatty Liver Disease, Non Alcoholic Steatohepatitis Trial in Giza (Genomics (DNA Extraction), Epi-genomics,
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- Non Alcoholic Steatohepatitis
- Genomics (DNA Extraction)
- +4 more
-
Giza, Al Jizah, EgyptNational Research Centre
Jun 1, 2022
SGLT-2 Inhibitors in T2DM and Moderate to Severe Liver Fibrosis
Completed
- Type2diabetes
-
New Delhi, Delhi, IndiaFortis CDOC Hospital
Jul 14, 2023
Nonalcoholic Fatty Liver Disease Trial in Dongguan (Silibinin extract, mixed power of pueraria, schisandra and salvia
Recruiting
- Nonalcoholic Fatty Liver Disease
- Silibinin extract, mixed power of pueraria, schisandra and salvia miltiorrhiza
- +2 more
-
Dongguan, Guangdong, ChinaDepartment of Nutrition, School of Public Health, Guangdong Medi
Aug 9, 2022
NAFLD, NASH - Nonalcoholic Steatohepatitis Trial in Indianapolis (Liver Incytes)
Recruiting
- NAFLD
- NASH - Nonalcoholic Steatohepatitis
- Liver Incytes
-
Indianapolis, IndianaIndiana University Division of Gastroenterolgy and Hepatology
Jan 25, 2022
Type 2 Diabetes Trial in Changsha (CMNT diet)
Recruiting
- Type 2 Diabetes
- CMNT diet
-
Changsha, Hunan, ChinaJinheyuan Outpatient Department, National Sub-health Interventio
Jun 27, 2022
Non-Alcoholic Fatty Liver Disease Trial (Phosphatidyl Choline)
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- Phosphatidyl Choline
- (no location specified)
Jan 15, 2022
Non-Alcoholic Fatty Liver Disease, Insulin Resistance, High Intensity Interval Training Trial in Little Rock (High-Intensity
Active, not recruiting
- Non-Alcoholic Fatty Liver Disease
- +3 more
- High-Intensity Interval Training (HIIT)
-
Little Rock, Arkansas
- +1 more
Aug 17, 2022